Since its September 2021 $13m (£10m) funding round, Locate Bio has continued the development of its range of orthobiologics focused on improving outcomes from orthopedic surgery.

As Omicron further destabilizes the medtech space, potentially mirroring the spring of 2020, some executives shared with Medtech Insight their views on what will hopefully be a bumper year for the sector.

The money will be used to further clinical research for its innovative, drug releasing, bone grafting products.